A study reveals that the majority of Chinese patients with hemophilia A depend on on-demand therapy, resulting in limited ...

Consider alternative treatment for hemophilia in patients with a history of symptomatic gallbladder disease. Serious thrombotic events have been reported in Qfitlia-treated patients. Thrombotic ...

J.R. Landry became one of only a handful in the nation, and the first in Rhode Island, to get what doctors believe will be ...

Columnist G Shellye Horowitz says that understanding which hemophilia treatments don't work in her body is as critical as ...

Subsequent studies by other investigators confirmed those early results, ultimately leading to the FDA approval of ...

In a 13-year follow-up by St. Jude Children’s Research Hospital and University College London published in The New England ...

It was found that those with severe hemophilia B have less than 1% of normal factor IX activity, often experiencing spontaneous bleeding that can cause joint damage or life-threatening events.

The Hemophilia B treatment landscape is entering a new era, marked by disruptive innovation, curative potential, and renewed global attention. Once viewed as a lifelong burden requiring constant ...

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists ...